Sezary syndrome is a cutaneous T cell lymphoma characterized by infiltration of the skin by CD4+ cells. These cells generally respond poorly to mitogens and T cell activators. We have studied the action of ILl to IL4, IL6, and IL7 on the proliferation of Sezary cells from 12 patients. With the exception of IL2 and IL7, the cytokines studied had no proliferative effect on these cells. Whereas IL2 had only a low proliferative capacity (twoto threefold increase) on peripheral blood mononuclear cells, recombinant IL7 constantly induced a very significant (340-fold increase) proliferative response, and was used successfully to generate cell lines in three out of eight cases. Growth of Sezary cell lines was shown to be strictly dependent on IL7, and after 2-5 wk of culture presented a switch to a homogeneous phenotype CD3+4+8-7-(except for one line that remained CD7+), with a typical morphology of Sezary cells. Their tumoral origin was demonstrated by the expression of the same T cell receptor-13 gene rearrangement as the patients' T cells. Importantly, cultured normal epidermal keratinocyte supernatants could support the growth of our Sezary lines. Furthermore, the proliferative activity contained in these supernatants was completely blocked by a monoclonal anti-IL7 antibody. These results suggest that IL7 may, therefore, represent an important cytokine in the physiopathology of cutaneous T cell lymphoma. (J. Clin. Invest. 1992. 90:1054-1060
Introduction
Sezary syndrome is a lymphoproliferative disorder characterized by infiltration of the skin by malignant T cells (1) . It is associated with erythroderma, generalized lymphadenopathy, and circulating neoplastic cells containing convoluted cerebriform nuclei (2, 3) . Sezary cells are of mature T helper phenotype (4) (5) (6) , although lack of CD7 antigen expression is a general feature of these cells (7, 8) . In contrast to adult T cell leukemia/lymphoma, an aggressive disorder that has been shown to be associated with infection by HTLV-I, Sezary syndrome is a relatively indolent disorder of unknown ethiology, those cells respond poorly to T cell mitogens, to CD2 and CD3 pathways ofactivation, and to IL2 (9-1 1 ). This low responsiveness explains why attempts to grow these cells are generally unsuccessful, and could be attributed to requirements for a growth factor distinct from IL2 (12) (13) (14) .
We have studied the action of cytokines relevant to T cell proliferation: ILl to IL4, IL6, and IL7 on PBMC from 12 patients. We found that among these molecules, only IL2 and IL7 had significant growth effect. However, whereas IL2 had a limited and inconstant effect, IL7 induced a very significant growth (3-40-fold increase) of these cells. IL7, originally described as a mouse pre-B cell growth factor, has been shown to induce human peripheral blood T cell proliferation (15, 16) . Interestingly, IL7 is produced by mesenchymal cells, but not by T cells ( 16) . Responsiveness to IL7 gave a selective advantage to tumoral cells, since we were able to enrich PBL from four patients in Sezary cells within 3 wk of culture. This led to the establishment ofthree IL7-dependent cell lines with a homogenous CD3+4+8-7-phenotype (except for one line which remained CD7+), typical Sezary morphology, and the same T cell receptor (TCR)-13 gene rearrangement as the patients' blood T cells. Sezary/ mycosis fungoides syndrome is generally associated with hyperkeratosis. In addition, it has been shown that tumoral cells proliferate in the skin but not in blood ( 17, 18 ). We also demonstrate here that supernatants from various epithelial cells could induce Sezary cell growth caused by IL7 production by these epithelial cells. Thus, IL7 production by epidermal keratinocytes may be an essential factor for the maintenance of malignant T cell cycling and tumor progression in Sezary syndrome/mycosis fungoides.
Methods
Patients. We studied 12 patients with their informed consent, 9 males and 3 females, (onset of disease: 38-79 yr age/mean: 59±10.5, evolution at the time of diagnosis: 0-12 yr, mean 3.5±4 yr), followed in dermatology departments of the Avicenne and Henri Mondor hospitals. All patients had generalized erythroderma with various associated signs, including hyperkeratosis, severe itching, and exfoliation. Cytokines. rILlf (50 U/ml), rIL-2 (50 U/ml), rIL3 (50 U/ml), and rIL4 (100 U/ml), all from Sandoz (Geneva, Switzerland), rIL6 (10 U/ml, kind gift of C. Damais, Paris, France), rIL7 (10 ng/ml, Tebu, LePerray en Yvelines, France). Human IL7 was also used as supernatants of a murine bone marrow-derived stromal cell line (M2 10B4) infected with a retrovirus (JZEN-TK.Neo) containing the human IL7 gene (M21OB4-hIL7). Mock supernatants used as control were obtained from M2 10B4 infected with the original retroviral vector (D. Thacker).
Proliferation assay. Cells 105/0. 1 ml were incubated in triplicate in 96-well round bottom plates with PHA-M (10 ,g/ml from Sigma Chemical Co., St. Louis, MO), or cytokines in RPMI 1640 10% FCS (Seromed, Berlin, Germany). Cultures were pulsed overnight with 1 ztCi/well [3H] thymidine (CEA Gif/Yvette, France), and radioactivity was measured on days 3 and 6 of culture by liquid scintillation counting (Beckman, Gagny, France).
T cell culture. PBMC from patients were cultured at 5 x 105/ml with 20% M2 10B4-hIL7 supernatant ( IL7-sup) in RPMI 1640 supplemented with 10% FCS. Some cultures were initiated with autologous serum in place of FCS during the first 2 wk of culture. Medium was changed twice a week, and cultures were split when cell concentration reached 2 x 106 cells/ml. Cells were cultured thereafter by half medium changed every 2-3 d, and maintained at 0.5-1 x 106/ml. To show dependency, some cultures were switched to IL-7-free medium by replacing IL-7-sup with 20% M210B4-Neo supernatant (Mock-sup).
Epithelial cell culture. Epithelial cells were collected from children undergoing corrective surgery ofthe abdomen or ears, as described (19, 20) , slightly modified. Briefly, skin was cut into pieces of 1 cm2 and floated on 0.25% trypsin for 1 h at 37°C. Cell suspension was removed and trypsin was inactivated with FCS. Cells were then washed in RPMI 1640 with 100,ug/ml DNAse and cultured in flasks at 4,000 cells/cm2, and viability, assessed by trypan blue exclusion, was always > 90%. Culture medium used was DME (Flow Laboratories, Irvine, Scotland) containing 10% FCS, 100 mM pyruvate, 200 mM glutamin, 4.5 g/liter glucose, 3.7 g/l NaHCO3, 100,ug/ml penicillin, 100,gg/ml streptomycin, 2.5 Ag/ml Amphotericin B, 0.4 ,ug/ml hydrocortisone, 20 ng/ml EGF, and 10-10 M cholera toxin (all from Sigma). Medium was changed every 3-4 d and cells were grown to confluence within 4-6 wk.
Keratinocyte nature was assessed by positive immunostaining with anticytokeratin, but not by antivimentin antibodies, as previously described (20) . For IL7 production, confluent cultures were washed with culture medium and incubated for 48 h with 2 ml medium per 25 cm2 flask.
Southern blot analysis. DNA was extracted and purified from Sezary PBMC and from established cell lines from three patients (BEL, CHA, RIC), according to standard procedure (21) . For TCR-# gene rearrangement, 10 ,ug of genomic DNA were digested with BamHI, EcoRI, and HindIll restriction enzymes and separated by electrophoresis in 0.6% agarose gel. Separated DNA fragments were then transferred onto nylon membrane (Hybond N; Amersham, Les Ulis, France), and hybridized with 32P-labeled probe specific for Cfll and C,B2 TCR-,B constant regions (22) . Autoradiography was performed by exposure on Kodak X-AR5 film with intensifying screens.
IL-7 bioassay. IL-7 bioactivity was measured using a thymocyte proliferation assay based on the direct mitogenic activity of both murine and human IL7 on murine thymocytes (23) . Briefly, 3-wk-old BALB/c thymocytes were cultured at 106 cells per well in 0.2 ml of RPMI 1640 medium supplemented with 10% FCS, 5 x I0 -M 2-mercaptoethanol, 200 ug/ml glutamine, and containing serial dilutions of the supernatant to be assayed or known concentrations of purified recombinant human IL7. After 3 d, cultures were pulsed with 1 qCi per well [3H ] TdR and harvested 6 h later for counting. In these conditions, all the mitogenic activity contained in the supernatants could be blocked by a saturating dose of anti-IL7 mAb.
Results
Immunologic phenotype ofPBMC. PBMC were isolated from blood samples of patients, by centrifugation over Ficoll gradient. Lymphocytosis of patients ranged from 6,000 to 80,000/ mm3, and Sezary cells, as atypical lymphocytes with cerebriform convoluted nuclei, determined by morphological examination, represent 15-85% of total patients' lymphocytes. As shown in Table I , CD4+ cells ranged from 44 to 97%, (in large excess over CD8 + cells) in all the patients. CD7 is a pan-T cell marker expressed on > 90% of CD4+ cells of normal PBMC (7). In our series, the percentage of atypical lymphocytes almost correlated with a low number ofCD7 + cells: as shown, all the patients with at least 60% ofatypical lymphocytes have 15% Proliferative responses of PBMC. The proliferative responses of PBMC were compared, using a T cell mitogen (PHA) and various cytokines (Table II) . As shown, PBMC from the 12 Sezary patients were only weakly proliferating on day 3 to PHA and the level of mitogenic response does not correlate with the disease stage nor the proportion of Sezary cells in the blood. Although PHA induced T cell proliferation is mainly considered as IL2 dependent, direct IL2 response of patients' PBMC was absent or weak (two-to threefold increase). One exception is patient CHA, who had 38% of CD25 + lymphoid cells and responded to recombinant IL2 with a proliferative index of 9. Other cytokines, IL13, IL3, and IL4, did not induce any significant proliferation on a 3-d assay. In contrast, recombinant IL7 could generate in all patients a very substantial (3-to 40-fold increase) proliferative response.
When compared to normal T cells, the IL7 response peaked on days 2-3 on Sezary PBMC, while normal cells showed maximal proliferation on days 6-7. Based on these data, IL7 is the best cytokine we tested capable to induce Sezary cell proliferation.
Establishment ofIL7 dependent lymphoma cell lines. Next, we tried to test the capacity of IL7 to maintain in long term culture human Sezary cells. For this, PBMC from eight patients were cultured with supernatant of a human 1L7-producing mouse stromal cell line (M210B4-hIL7). This line, in which the human IL7 gene has been introduced by retroviral gene transfert (provided by Dean J. Thacker), produced on a regular basis 40-60 ng/ml ofhIL7 in the supernatant. Cultures were maintained as described in Methods. Fig. 1 A show the establishment and growth characteristics of a cell line from patient RIC on the initial 10 wk of culture. In IL7 containing medium, a slow but regular growth is observed, with a doubling time of about 10 d. When the culture is switched to medium containing supernatant from control stromal line (M2 10B4.Neo) containing the retroviral vector only, the cells stopped to multiply and eventually died within 4-5 wk. Fig. 1 B confirmed on established culture the IL7 dependency. Proliferation was measured by [3H I thymidine incorporation on aliquots of cultures maintained on IL7 containing medium or mock supernatant. As shown on two cell lines, while proliferation was sustained in the continuous presence ofIL7, depletion ofthis cytokine induces a dramatic decrease ofthe proliferation rate of these cell.
To further confirm that IL7 was the only growth factor involved in the proliferative capacity of the M2 10B4-1L7 supematant, blockade experiments with anti-IL7 MAb were performed (Fig. 2) . Results confirm the absence of activity in mock supernatant (M210B4-Neo), while proliferation induced by M210B4-hIL7 could be inhibited in a dose-dependent manner by mAb; complete blockage was achieved by 2 tg of anti-IL7 mAb.
These results demonstrate that long term culture from peripheral blood of Sezary patients can be established and maintained with IL7. On the eight patients (BEL, BIL, BOS, CHA, CLA, LAV, RIC, and ZIC), we tried to derive cell lines, although all responded initially to IL7 and could be cultured for 2-10 wk, three lines (CHA, BEL, and RIC) could be successfully established. One (LAV) was lost by spontaneous EBV-B cell overgrowth.
Phenotypic analysis of Sezary lines. As previously mentioned from phenotypic analysis of patients' PBMC, loss of CD7 expression broadly correlated with the percentage ofatypical lymphocytes. Therefore, we compared the time course expression ofCD4 and CD7 markers during the first 10 wk ofcell culture in IL7. As shown in Fig. 3 , starting from 60 to 88% of CD4+ cells in the four patients used in these experiments (BEL, CHA, RIC, and CLA) showed an increased CD4 expression over time. More importantly, during the same period, should provide a suitable microenvironment for Sezary cells. Therefore, we tested the capacity of cultured epidermal keratinocytes from normal individuals to support the proliferation of our Sezary lines. As shown in Fig. 5 , supernatants from these cells could induce a dose-dependent proliferative response of Sezary cells. In addition, this proliferation could be completely specifically blocked by a saturating dose ofanti-IL7 mAb, since a similar dose of isotype matched anti-IL3 mAb was ineffective. These data demonstrate the production of IL7 by unstimulated cultured cytokeratin+ vimentin -keratinocytes.
To better estimate the level of IL7 production by keratinocytes, bioactivity of several supernatants was quantified in a mouse thymocyte proliferation assay. Table III summarizes the results obtained. As expected, M2 10B4-Neo supernatant was devoid of any IL7 activity, whereas M2 10B4-hIL7 produced , 40-60 ng/ ml ofhIL7. The other control used, thymic epithelial cells cultured in the same conditions as keratinocytes, also showed high levels of IL7 production (150 ng/ml). In these conditions, IL7 activity contained in keratinocyte supernatants ranged between 15 and 60 ng/ml, whereas Sezary lines from patients CHA and RIC did not produce any activity. These data may suggest a possible in vivo paracrine growth of Sezary cells in the skin. the disease has remained unclear, studies being hampered by the lack of in vitro model. While T cells proliferating in the skin are difficult to access, circulating lymphocytes are usually refractory to T cell mitogen stimulations (9-1 1 ). Despite occasional response of some patients to IL2 this insensitivity to stimulation explain that establishment of Sezary cell lines have generally been unsuccessful (12) (13) (14) . IL7, initially described as a pre-B cell growth factor, is a cytokine produced by mesenchymal cells, which can also sustain the proliferation of thymocytes and human peripheral blood T cells ( 15, 16 ). Here we demonstrate that IL7 is a potent growth factor on peripheral blood Sezary cells, and can be used to generate in vitro stable 1L7-dependent malignant cell lines.
We studied a series of 12 Sezary patients with advanced disease and 15-85% atypical Sezary cells in the blood. As reported, immunofluorescence studies of patients' PBMC suggest a classical CD4 + resting helper T cell phenotype for circulation lymphoma cells (3) (4) (5) (6) . Lack of Leu8 and CD7 expression on peripheral blood Sezary cells have been previously reported and proposed as a marker for circulating Sezary cells, allowing distinction of cutaneous T cell lymphoma from acute T cell leukemias (CD7+) (7, 8) . In our study, lack of expres- MAbs. Proliferation was measured by thymidine incorporation on day 3. sion of CD4 + CD7 -phenotype correlated quite well with the percentage of atypical lymphocytes in the blood. We also observed a progressive loss of CD7-expressing cells during the initial period of establishment of our Sezary cell lines. However, in one patient initially expressing a high percentage of CD4+CD7+ PBMC, a maintenance of this phenotype was noted in the malignant cell line. Despite this exception, we believe that a CD7 -phenotype, associated with a large excess of CD4 to CD8 expression, is a good marker for cutaneous T cell lymphoma. In addition, our ability to maintain CD7 + RIC Sezary cells in long term culture militates against a possible modulation of CD7 antigen expression or a preferential growth of CD7 -normal T cells, because of the culture conditions we used.
Refractoriness of Sezary cells to respond to T cell stimuli is a common observation. One possible explanation is the need for an activation signal and/ or a particular cytokine ( s) requirement for Sezary cell proliferation. This is illustrated by the fact that, although circulating malignant cells are usually resting, skin-infiltrating T cells from mycosis fungoides/Sezary syndrome patients have an activated phenotype, expressing Tac and HLA-DR, and are in active cell cycling (8) . Proliferative response to IL2 can sometimes be observed, but as in our study, most of the patients PBMC failed to respond or responded poorly to this cytokine. Preactivation usually increases or induces IL2 responsiveness ( 14) . However, physiological relevance for IL2 induced proliferation in the skin is unclear because Sezary cells usually failed to produce sufficient amount of IL2 to support their own proliferation, and other sources in the skin are not obvious (24). In this context, our observation that recombinant IL7 could directly induce the proliferation of PBMC from all the patients we tested is of importance. We also observed that this proliferation is not blocked by Cyclosporin A, confirming that 1L7-induced response is not IL2-mediated. In addition, while proliferation of Sezary PBMC response to IL7 reached a plateau on days 3-4, that of normal T cells needed 6-7 d (25, 26) . This kinetic suggests that the proliferative cells responding to IL7 belonged primarily to the malignant compartment.
This strong proliferation to IL7 allowed us to test the possibility to maintain in long term lymphoma cells. Eight patients were evaluated, all grew well for at least 2-6 wk; three could be established as IL7-dependent cell line. A fourth one was lost at week 6 by EBV B cell overgrowth. Reasons for failure to maintain other lines for longer period is unclear, however, IL7 have been reported to induce cytotoxic T cell generation (27) (28) (29) . Cell lines were maintained in medium containing supernatant from a mouse stromal cell line containing the human IL7 gene by retroviral-mediated gene transfer (M2 lOB4-hIL7). IL7 dependency was demonstrated by progressive death of cells after switching to medium containing supernatant from control cell line (M2 1OB4-Neo). The implication ofHTLV-I as a potential etiologic agent for mycosis fungoides/Sezary syndrome has been suggested, although contradictory reports exist in the literature ( 30, 31 ) . Although our patients were serologically negative for HTLV-I (data not shown), we haven't tested the absence of viral sequences in the lymphocytes, however, exogenous IL7 dependency ofour cells indicates that ifHTLV-I is by any way necessary, it is not sufficient for cell line maintenance.
The cells grow slowly in culture, with a mean doubling time of 10 d, which is consistent with the relatively indolent nature of this disorder. Importantly, beside the homogeneity of the phenotype, cell line presented the typical morphology of Sezary cells on May Grunwald-Giemsa staining with a convoluted cerebriform nuclei. Furthermore, analysis of TCR-,B chain gene rearrangement demonstrate that for three lines, an identical rearranged band is evidenced when comparing the blood and cultured Sezary cells. This ascertains that the lines are relevant to the malignant clone. It also suggests that Sezary cells have a selective growth advantage for IL7 responsiveness. Of note, we failed to maintain in long term culture normal PBMC with IL7.
As mentioned above, Sezary cells are activated and proliferate in the skin of mycosis fungoides/Sezary syndrome and are associated with hyperkeratosis. This leads us to investigate the production of IL7 by cultured keratinocytes. We showed that indeed these cells produce a factor that could induce the proliferation of the lymphoma cells and that could be blocked by anti-IL7 mAb. In addition, IL7 content could be measured in a bioassay and ranged between 15 and 60 ng/ ml, a dose comparable to those of the IL7-producing cell line we used to maintain our Sezary lines. This production is not limited to epidermal epithelial cells, since (as shown in Table III ) thymic epithelial cells cultured in the same conditions as keratinocytes also produced IL7, as previously reported ( 15, 16) .
Tumors arise as a result of multiple oncogeneic events on continuously cycling cells. Chronic stimulation and exacerbated cytokine-induced proliferation, augment the risk of transformation and certainly play an important role in tumor progression. This can be illustrated by the implication of IL6 and IL2 in the evolution of multiple myeloma and Waldenstrom macroglobulinemia, and ofadult T cell leukemia, respectively (32-35). IL7 has also been presented as a proliferating factor for pre-B and T acute lymphoblastic leukemias (36, 37) .
In conclusion, for the first time, we demonstrated that IL7 is a potent growth factor for Sezary cells, and may be an important paracrine cytokine in the physiopathology of cutaneous T cell lymphoma.
